Evidence map›Paper›PMID 24009040›Full record

ArticleNeuro-degenerative diseases2014

Functional interaction between amyloid-β precursor protein and peripherin neurofilaments: a shared pathway leading to Alzheimer's disease and amyotrophic lateral sclerosis?

Virgil Muresan, Christine Villegas, Zoia Ladescu Muresan

Abstract read
In one paragraph

Article in Neuro-degenerative diseases, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
1.4field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 19 citations in OpenAlex.

  1. Review
  2. Peripherin, A New Promising Biomarker in Neurological Disorders.The European journal of neuroscience · 2025
    Review
  3. Article
  4. Does SCFD1 rs10139154 Polymorphism Decrease Alzheimer's Disease Risk?Journal of molecular neuroscience : MN · 2019
    Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Virgil MuresanDepartment of Pharmacology and Physiology, Rutgers, The State University of New Jersey, New Jersey Medical School, Newark, N.J., USA.
Christine Villegas
Zoia Ladescu Muresan
Rutgers, The State University of New Jersey · US

Funding

Reporter Mice For APP Processing And TransportR21AG039668 · NIA · UNIV OF MED/DENT OF NJ-NJ MEDICAL SCHOOL · PI MURESAN, ZOIA · 2011 to 2012
$352k
NIA NIH HHS AG039668NIA NIH HHS R21 AG039668
6 · The paper itself

Abstract

BACKGROUND AND

objectiveThe pathology of amyotrophic lateral sclerosis (ALS), a neurodegenerative disorder affecting motor neurons, comprises aberrant accumulations of neurofilaments; mutations in the peripherin subunit of neurofilaments have been identified in some forms of ALS. Recently, the amyloid-β precursor protein (APP), a key element for the pathology of Alzheimer's disease (AD), was linked to ALS. Here, we provide evidence that the generation of the N-terminal fragment of APP, sAPP, relies on peripherin neurofilaments. This finding could relate to a novel molecular mechanism dysregulated in ALS and/or AD. METHODS AND

resultsThe production and the fate of sAPP were studied with the brainstem-derived, neuronal cell line, CAD, which expresses endogenous peripherin. We show that sAPP and C-terminal fragments (CTF) are generated to a large extent in the neuronal soma. We find that sAPP, but not CTF, associates with filamentous structures that delineate the nuclear lamina, extend to the cell periphery and immunostain for peripherin. The depletion of peripherin with siRNA eliminates the filamentous immunostaining of sAPP.

conclusionOur results indicate that a fraction of APP is cleaved by β-secretase in the soma and that the generated sAPP becomes associated with perinuclear peripherin neurofilaments. These findings link the metabolism of APP--which is dysregulated in AD--to the organization of neurofilaments--which is abnormal in ALS--and suggest a possible crosstalk/overlap between the molecular mechanisms of these diseases.

Indexed as

Alzheimer DiseaseAmyloid beta-Protein PrecursorAmyloid Precursor Protein SecretasesAmyotrophic Lateral SclerosisAnimalsCell LineMiceNeuronsPeripherinsAmyloid beta-Protein PrecursorAmyloid Precursor Protein SecretasesPeripherins

Identifiers

PMID24009040
PMCPMC4286376
OpenAlexW2049350175

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.